Clinical Trial: GTA-Glyceryltriacetate for Canavan Disease

Study Status: Recruiting
Recruit Status: Unknown status
Study Type: Interventional




Official Title: Phase 1 Treatment With GTA in Two Infant With Canavan Disease

Brief Summary: The purpose of this study is to determine whether oral supplementation of glyceryl triacetate improves the clinical prognosis of Canavan Disease.